Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,336 | -7,582 | -6,072 | -4,297 | -7,896 |
| Depreciation Amortization | 113 | 179 | 134 | 89 | 172 |
| Accounts payable and accrued liabilities | N/A | N/A | 624 | 291 | N/A |
| Other Working Capital | 10 | 757 | 1,554 | 890 | 177 |
| Other Operating Activity | 312 | 1,169 | -83 | 210 | 720 |
| Operating Cash Flow | $-901 | $-5,477 | $-3,843 | $-2,817 | $-6,827 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 205 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 2,250 | 0 | 0 | 2,050 |
| Financing Cash Flow | $205 | $2,250 | $N/A | $N/A | $2,050 |
| Beginning Cash Position | 1,312 | 4,539 | 4,539 | 4,539 | 9,316 |
| End Cash Position | 616 | 1,312 | 697 | 1,722 | 4,539 |
| Net Cash Flow | $-696 | $-3,227 | $-3,843 | $-2,817 | $-4,777 |
| Free Cash Flow | |||||
| Operating Cash Flow | -901 | -5,477 | -3,843 | -2,817 | -6,827 |
| Free Cash Flow | -901 | -5,477 | -3,843 | -2,817 | -6,827 |